Hilde Johnsen

36.1k total citations · 5 hit papers
26 papers, 26.5k citations indexed

About

Hilde Johnsen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hilde Johnsen has authored 26 papers receiving a total of 26.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Hilde Johnsen's work include Gene expression and cancer classification (10 papers), Molecular Biology Techniques and Applications (8 papers) and Breast Cancer Treatment Studies (7 papers). Hilde Johnsen is often cited by papers focused on Gene expression and cancer classification (10 papers), Molecular Biology Techniques and Applications (8 papers) and Breast Cancer Treatment Studies (7 papers). Hilde Johnsen collaborates with scholars based in Norway, United States and Israel. Hilde Johnsen's co-authors include Per Eystein Lønning, Thérese Sørlie, Patrick O. Brown, Charles M. Perou, David Botstein, Stefanie S. Jeffrey, Matt van de Rijn, Michael B. Eisen, Stephanie Geisler and Anne‐Lise Børresen‐Dale and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Hilde Johnsen

24 papers receiving 25.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular portraits of human breast tumours

2000 11.7k citations Charles M. Perou, Thérese Sørlie et al. Nature profile →
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

2001 8.3k citations Thérese Sørlie, Charles M. Perou et al. profile →
Repeated observation of breast tumor subtypes in independent gene expression data sets

2003 4.0k citations Thérese Sørlie, Hilde Johnsen et al. profile →
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1996 608 citations Turid Aas, Anne‐Lise Børresen et al. Nature Medicine profile →
Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays

1999 531 citations Jonathan R. Pollack, Charles M. Perou et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hilde Johnsen Norway	17	13.6k	13.3k	13.3k	4.0k	3.4k	26	26.5k
Anne‐Lise Børresen‐Dale Norway	65	14.8k 1.1×	12.4k 0.9×	10.9k 0.8×	4.5k 1.1×	3.0k 0.9×	190	26.0k
Thérese Sørlie Norway	34	16.2k 1.2×	15.0k 1.1×	15.0k 1.1×	4.9k 1.2×	3.8k 1.1×	92	31.0k
John A. Foekens Netherlands	79	13.5k 1.0×	10.6k 0.8×	11.4k 0.9×	3.3k 0.8×	3.6k 1.1×	337	25.5k
Stefanie S. Jeffrey United States	51	16.6k 1.2×	14.9k 1.1×	13.8k 1.0×	4.7k 1.2×	3.9k 1.2×	138	33.6k
Lars A. Akslen Norway	67	13.8k 1.0×	11.6k 0.9×	14.0k 1.1×	3.3k 0.8×	4.4k 1.3×	314	29.1k
Maggie C.U. Cheang United States	47	7.4k 0.5×	12.4k 0.9×	12.6k 0.9×	2.6k 0.7×	4.0k 1.2×	122	21.3k
Matthew J. Ellis United States	65	9.0k 0.7×	13.1k 1.0×	15.9k 1.2×	4.7k 1.2×	6.7k 2.0×	321	26.9k
C. Kent Osborne United States	79	10.7k 0.8×	8.8k 0.7×	14.8k 1.1×	8.7k 2.2×	4.0k 1.2×	173	25.4k
Christos Sotiriou Belgium	76	12.3k 0.9×	13.8k 1.0×	15.6k 1.2×	2.9k 0.7×	4.4k 1.3×	366	29.1k
Ana M. González-Angulo United States	83	8.9k 0.7×	11.4k 0.9×	15.2k 1.1×	2.6k 0.6×	5.2k 1.5×	281	25.2k

Countries citing papers authored by Hilde Johnsen

Since Specialization

Citations

This map shows the geographic impact of Hilde Johnsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilde Johnsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilde Johnsen more than expected).

Fields of papers citing papers by Hilde Johnsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilde Johnsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilde Johnsen. The network helps show where Hilde Johnsen may publish in the future.

Co-authorship network of co-authors of Hilde Johnsen

This figure shows the co-authorship network connecting the top 25 collaborators of Hilde Johnsen. A scholar is included among the top collaborators of Hilde Johnsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilde Johnsen. Hilde Johnsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnsen, Hilde, et al.. (2019). Diagnostics of Hereditary Connective Tissue Disorders by Genetic Next-Generation Sequencing. Genetic Testing and Molecular Biomarkers. 23(11). 783–790. 7 indexed citations

Williams, Cheryl, Hilde Johnsen, Lars A. Akslen, et al.. (2019). Molecular portraits of human breast tumours. UNC Libraries.

Sørlie, Thérese, Hilde Johnsen, Phuong Vu, et al.. (2014). Mutation Screening of the TP53 Gene by Temporal Temperature Gel Electrophoresis (TTGE). Methods in molecular biology. 1105. 315–324.

Enerly, Espen, Israel Steinfeld, Kristine Kleivi Sahlberg, et al.. (2013). Correction: miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors. PLoS ONE. 8(9). 1 indexed citations

Enerly, Espen, Israel Steinfeld, Kristine Kleivi Sahlberg, et al.. (2011). miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors. PLoS ONE. 6(2). e16915–e16915. 245 indexed citations

Hallett, Michael, Hilde Johnsen, Kristine Kleivi Sahlberg, et al.. (2010). Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. Molecular Oncology. 4(4). 357–368. 91 indexed citations

Borgan, Eldrid, Beathe Sitter, Ole Christian Lingjærde, et al.. (2010). Merging transcriptomics and metabolomics - advances in breast cancer profiling. BMC Cancer. 10(1). 92 indexed citations

Enerly, Espen, Israel Steinfeld, Kristine Kleivi Sahlberg, et al.. (2010). 648 Molecular characterization of breast cancer subtypes derived from joint analysis of high throughput miRNA and mRNA data. European Journal of Cancer Supplements. 8(5). 164–164. 2 indexed citations

Bergamaschi, Anna, Geir Olav Hjortland, Tiziana Triulzi, et al.. (2009). Molecular profiling and characterization of luminal‐like and basal‐like in vivo breast cancer xenograft models. Molecular Oncology. 3(5-6). 469–482. 86 indexed citations

10.

Helland, Åslaug, Hilde Johnsen, Anna Barbro Sætersdal, et al.. (2006). Radiation-induced effects on gene expression: An in vivo study on breast cancer. Radiotherapy and Oncology. 80(2). 230–235. 17 indexed citations

11.

Johnsen, Hilde, Debra A. Barnes, Adam B. Steel, et al.. (2006). Evaluation of MetriGenix custom 4D™ arrays applied for detection of breast cancer subtypes. BMC Cancer. 6(1). 59–59. 7 indexed citations

12.

Sørlie, Thérese, Yulei Wang, Chunlin Xiao, et al.. (2006). Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics. 7(1). 127–127. 289 indexed citations

13.

Sørlie, Thérese, Hilde Johnsen, Phuong Vu, et al.. (2004). Mutation Screening of the <I>TP53</I> Gene by Temporal Temperature Gradient Gel Electrophoresis. Humana Press eBooks. 291. 207–216. 20 indexed citations

14.

Geisler, Stephanie, Anne‐Lise Børresen‐Dale, Hilde Johnsen, et al.. (2003). TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer.. PubMed. 9(15). 5582–8. 118 indexed citations

15.

Geisler, Stephanie, Per Eystein Lønning, Turid Aas, et al.. (2001). Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.. PubMed. 61(6). 2505–12. 264 indexed citations

16.

Perou, Charles M., Thérese Sørlie, Michael B. Eisen, et al.. (2000). Molecular portraits of human breast tumours. Nature. 406(6797). 747–752. 11684 indexed citations breakdown →

17.

Pollack, Jonathan R., Charles M. Perou, Thérese Sørlie, et al.. (1999). Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays. Nature Genetics. 23(S3). 69–69. 531 indexed citations breakdown →

18.

Andersen, Tone Ikdahl, Hans Geir Eiken, Fergus J. Couch, et al.. (1998). Constant denaturant gel electrophoresis (CDGE) inBRCA1 mutation screening. Human Mutation. 11(2). 166–174. 16 indexed citations

19.

Lothe, Ragnhild A., Merete Hektoen, Hilde Johnsen, et al.. (1998). The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer.. PubMed. 58(14). 2923–4. 19 indexed citations

20.

Aas, Turid, Anne‐Lise Børresen, Stephanie Geisler, et al.. (1996). Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nature Medicine. 2(7). 811–814. 608 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact